The Question Every Woman Should Be Asking About Peptides Right Now

A practical guide to evaluating peptide vendors, separating real research from marketing language, and understanding what actually matters before you buy.

---

The peptide industry is having a moment.

Wellness influencers are talking about BPC-157. Longevity podcasters are debating NAD+ doses. Women in their forties are asking each other about Retatrutide on group texts that, three years ago, were about which collagen powder dissolved best in coffee. The conversation has shifted, the search volume has exploded, and an entirely new category of vendor has appeared online to meet the demand.

Most of these vendors are unregulated. Many of them are good. Some of them are not. The peptide market sits in a strange regulatory grey area where research-use-only framing creates room for legitimate suppliers and bad actors to operate side by side, often with websites that look almost identical from the outside.

For a woman trying to evaluate this category for the first time, the question that matters most isn’t which peptide should I buy? It’s how do I tell the real ones apart?

This piece is the answer. It’s a practical guide to evaluating peptide vendors written by people who built one. The standards below are the questions every customer should be asking, of every supplier, before they spend a dollar. Some of those questions will be uncomfortable for the industry to answer. That’s the point.

Question 1: Where is the Certificate of Analysis?

The single most important document in peptide research is the Certificate of Analysis, usually abbreviated as COA. It’s a third-party laboratory report that documents what’s actually in the vial. Not what the vendor claims is in the vial. What testing showed.

A real COA includes, at minimum:

• The compound’s identity, confirmed by mass spectrometry
• The compound’s purity, confirmed by HPLC (high-performance liquid chromatography)
• The batch or lot number that ties the test results to the specific production run
• The date of testing
• The name of the testing laboratory

A real vendor publishes the current batch’s COA on the product page itself and links to an archive of past COAs. You can verify them yourself.

A questionable vendor does one of three things: hides the COA behind an email request (“contact us for documentation”), publishes a single COA that’s reused across batches (a giveaway: the test date is over a year old), or shows a screenshot that has no laboratory name attached.

If you can’t read the COA without contacting the vendor, treat that as the answer. The COA is a basic transparency standard. A vendor that won’t show you one is telling you something about how they operate.

Question 2: What’s the actual purity, and how was it tested?

“99% pure” is a number that means nothing without context. The relevant questions are:

• Was purity measured by HPLC? (This is the standard. Other methods are not equivalent.)
• Was the test run by a third-party laboratory, or by the vendor’s own facility?
• Does the COA show the actual chromatogram, or just a number?

HPLC is the industry standard for peptide purity testing because it can detect contaminants, degradation products, and synthesis byproducts that other methods miss. A peptide can look right under simpler tests and still contain meaningful amounts of impurities that change how it behaves.

Third-party testing matters because it removes the conflict of interest. A vendor testing their own product has every incentive to find purity. An independent laboratory does not.

The chromatogram itself is what dedicated researchers actually look at. It’s a graph showing peaks for every compound detected in the sample. A pure peptide shows one major peak with minor noise around it. An adulterated peptide shows multiple peaks. You don’t need to be a chemist to see the difference once you know to look for it.

When a vendor publishes only a number (“99.7% purity”) without a chromatogram, the number isn’t independently verifiable. When a vendor publishes the chromatogram, the entire test is open to scrutiny. The first is a claim. The second is evidence.

Question 3: What does the research actually say?

This is where the industry gets uncomfortable.

Most peptide vendor websites describe their products in language that is technically true but practically meaningless. A typical product page might claim a peptide “supports recovery,” “promotes wellness,” or “has been studied for its role in optimizing performance.” These statements aren’t lies. They’re also not science.

The questions that produce real answers:

• Has the peptide been studied in humans, or only in animals? Many peptides marketed as having decades of research have human trial data measured in dozens of subjects, while their animal model literature is vast. This matters because what happens in male rats does not always happen in humans. It happens often enough to be informative. It happens rarely enough to be cautious.
• Have studies included women specifically? Most peptide research, even today, has been conducted on men or in male animal models. There are exceptions (GHK-Cu, PT-141, kisspeptin), and we’ve written about the ones with substantial female-centered evidence in our on the peptide research women were left out of. For most peptides, women’s specific representation in the research base ranges from “included” to “not separately analyzed.”
• What’s the actual finding? “Studies have shown” is not a finding. “Promotes recovery” is not a finding. A finding is something like: “In a 12-week double-blind placebo-controlled trial of 71 women, treatment was associated with statistically significant increases in skin density and reductions in fine line depth.” The first three are marketing language. The last one is research.

A vendor whose product pages cannot distinguish between marketing language and research findings is signaling either that they don’t know the difference, or that they’re hoping their customers don’t.

Question 4: Where is the company actually based?

Peptide vendors operate globally. Some are based in the United States and ship from domestic facilities under U.S. legal frameworks. Others are based offshore, ship internationally, and operate in regulatory environments where consumer protections, manufacturing standards, and recourse for defective products may be limited or nonexistent.

This matters for several practical reasons:

• Quality control standards vary dramatically between jurisdictions. Domestic manufacturing under U.S. or EU standards is different from manufacturing in regions with no enforced standards.
• Customer recourse depends on where the company is legally based. A defective product from a domestic supplier is a small claim away from refund. A defective product from an offshore supplier is essentially nonrecoverable.
• Customs interception is a real risk for offshore shipments, particularly for products that exist in regulatory grey areas. Domestic suppliers don’t have this problem.

A legitimate vendor publishes a real business address, a real phone number, and a real legal entity name in the website footer. If the only contact information is a generic email address and the company location is vague or unstated, that’s the vendor signaling that they prefer not to be locatable. Make of that what you will.

Question 5: How do they handle storage, shipping, and stability?

Peptides are biologically active molecules. Many of them are unstable at room temperature, sensitive to light, and degrade quickly when reconstituted. The handling chain between a vendor’s facility and your laboratory matters.

A serious vendor:

• Ships peptides as lyophilized (freeze-dried) powder, the most stable form
• Provides clear storage instructions for both pre- and post-reconstitution states
• Uses appropriate packaging (sealed sterile vials, light-protective containers)
• Acknowledges stability limits honestly (most peptides have a 30-day window after reconstitution; some are shorter)
• Warns against freeze-thaw cycles, which degrade most peptides

A questionable vendor either glosses over storage requirements or makes vague claims that their product is stable indefinitely. The chemistry doesn’t support that.

What the answers actually tell you

The questions above aren’t really about peptides. They’re about the kind of company you’re buying from.

A vendor who publishes batch-matched COAs, shows their chromatograms, frames everything around research-use language, lists a real company and real address, and ships properly handled product is doing the work of being trustworthy. They’re not promising you outcomes they can’t deliver. They’re showing you what’s actually in the vial and letting the science speak for itself.

A vendor who hides COAs, publishes only purity numbers, makes promissory health claims, and operates from a location they’d rather not specify is asking you to trust them on faith. In an unregulated market, that faith is the actual product they’re selling. The peptide is secondary.

There are good vendors in this space. There are also vendors who exist because women searching for solutions to real problems will, eventually, click “buy” on something. The questions above are the simplest way to tell which is which.

What we built, and how we built it

We started NextSelf Labs because the questions above were the questions we wanted answered when we were the customer. The catalog is built around them.

Every product page publishes the current batch’s Certificate of Analysis with the chromatogram visible and the testing laboratory named. Every batch is tested by an independent third-party facility before it ships. Every product description is written in research-observational language because that’s the only language we’re legally allowed to use, and the only language that’s honest.

Where the research base for a peptide is strong (GHK-Cu, PT-141, kisspeptin), we say so, and we link to the studies. Where it’s thinner, we say that too. We frame relevance to women through what’s actually been studied, rather than inventing a women-centered story for products whose research literature doesn’t support one.

This is not the easiest way to run a peptide business. It is the way that produces a business worth running.

The questions above belong to every customer in this space, regardless of who they buy from. Print them out, save them, ask them of every vendor you consider. Real companies will answer them gladly. The other kind will, in their own way, also answer them. You just have to know what their silence means.

References

[^1]: U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.” FDA.gov. Discusses regulatory framework for compounded peptides and the bulk drug substances list.

[^2]: U.S. Pharmacopeia. USP General Chapter <1086>: Impurities in Drug Substances and Drug Products. Documents standard methodology for HPLC purity testing in peptide products.

[^3]: Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010). “Synthetic therapeutic peptides: science and market.” Drug Discovery Today, 15(1-2), 40 to 56. Provides overview of peptide manufacturing standards and quality assurance benchmarks.

[^4]: International Conference on Harmonisation. ICH Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products. Establishes the international standard for purity, identity, and stability testing of pharmaceutical compounds, including peptides.

[^5]: U.S. Food and Drug Administration. Drug Supply Chain Security Act (DSCSA). FDA.gov. Establishes traceability requirements that legitimate domestic suppliers comply with and offshore suppliers typically do not.

---

This piece reflects the views of NextSelf Labs and is intended for educational purposes. NextSelf Labs sells research peptides for laboratory use only. Products are not intended for human consumption, therapeutic use, or diagnostic application. Information presented here should not be construed as medical advice. Consult a qualified healthcare provider for any decisions regarding personal health.